Cargando…
Alterations in the Anandamide Metabolism in the Development of Neuropathic Pain
Endocannabinoids (EC), particularly anandamide (AEA), released constitutively in pain pathways might be accountable for the inhibitory effect on nociceptors. Pathogenesis of neuropathic pain may reflect complex remodeling of the dorsal root ganglia (DRGs) and spinal cord EC system. Multiple pathways...
Autores principales: | Malek, Natalia, Kucharczyk, Mateusz, Starowicz, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167645/ https://www.ncbi.nlm.nih.gov/pubmed/25276812 http://dx.doi.org/10.1155/2014/686908 |
Ejemplares similares
-
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism
por: Starowicz, Katarzyna, et al.
Publicado: (2013) -
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
por: Malek, Natalia, et al.
Publicado: (2015) -
Alterations in Anandamide Synthesis and Degradation during Osteoarthritis Progression in an Animal Model
por: Bryk, Marta, et al.
Publicado: (2020) -
Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013) -
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems—A Novel Treatment Option for Chronic Pain Management
por: Malek, Natalia, et al.
Publicado: (2016)